MedTrace Logo

Intrawound Vancomycin Powder in Spinal Fusion Surgery

NCT02631408 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 308

Last updated 2021-03-03

No results posted yet for this study

Summary

Vancomycin powder (for solution for Infusion) will be investigated (off-label usage) in spinal fusion surgery. The powder will be locally administered into to the wound cavity before wound closure.

Hypothesis: Locally applied vancomycin powder leads to a reduction in postoperative surgical site infections

Conditions

  • Spinal Fusion Acquired

Interventions

DRUG

Vancomycin

Locally, intrawound applied vancomycin powder

Sponsors & Collaborators

  • Orthopedic Hospital Vienna Speising

    lead OTHER

Principal Investigators

  • Philipp Becker, MD · Orthopedic Hospital Speising

  • Lukas Panzenboeck, MD · Orthopedic Hospital Speising

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2019-03-01
Completion
2021-03-01

Countries

  • Austria

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02631408 on ClinicalTrials.gov